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Background: Major depressive disorder (MDD) is a public health problem worldwide.
There is increasing interest in using non-invasive therapies such as repetitive transcranial
magnetic stimulation (rTMS) to treat MDD. However, the changes induced by rTMS on
neural circuits remain poorly characterized. The present study aims to test whether the
brain regions previously targeted by deep brain stimulation (DBS) in the treatment of
MDD respond to rTMS, and whether functional connectivity (FC) measures can predict
clinical response.
Methods: rTMS (20 sessions) was administered to five MDD patients at the left-
dorsolateral prefrontal cortex (L-DLPFC) over 4 weeks. Magnetoencephalography
(MEG) recordings and Montgomery-Asberg depression rating scale (MADRS)
assessments were acquired before, during and after treatment. Our primary measures,
obtained with MEG source imaging, were changes in power spectral density (PSD) and
changes in FC as measured using coherence.
Results: Of the five patients, four met the clinical response criterion (40% or
greater decrease in MADRS) after 4 weeks of treatment. An increase in gamma
power at the L-DLPFC was correlated with improvement in symptoms. We also
found that increases in delta band connectivity between L-DLPFC/amygdala and
L-DLPFC/pregenual anterior cingulate cortex (pACC), and decreases in gamma band
connectivity between L-DLPFC/subgenual anterior cingulate cortex (sACC), were
correlated with improvements in depressive symptoms.
Conclusions: Our results suggest that non-invasive intervention techniques, such as
rTMS, modulate the ongoing activity of depressive circuits targeted for DBS, and
that MEG can capture these changes. Gamma oscillations may originate from GABA-
mediated inhibition, which increases synchronization of large neuronal populations,
possibly leading to increased long-range FC. We postulate that responses to rTMS
could provide valuable insights into early evaluation of patient candidates for DBS
surgery.
Keywords: repetitive transcranial magnetic stimulation (rTMS), neuromodulation, dorsolateral prefrontal cortex
(DLPFC), depression, deep brain stimulation (DBS), functional connectivity
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INTRODUCTION
Major depressive disorder (MDD) is characterized by depressed
mood, anhedonia, irritability, poor concentration, feelings of
hopelessness, thoughts of self-harm, inappropriate guilt, and
abnormal appetite and sleep patterns. About a sixth of the
American population will suffer from clinical depression in their
lifetime. Because of its significant societal and economic impact
on the general population, both the underlying mechanism(s)
of MDD and markers of individual response to treatment are
important areas of ongoing research.
Previous studies have proposed that MDD is a circuit-based
disorder in which several regions of the brain (prefrontal
cortex, amygdala, striatum, pallidum and medial thalamus)
are functionally aberrant (Drevets et al., 1992). Activity in
the limbic regions, specifically the amygdala and anterior
cingulate cortex (ACC; Brodmann’s area 25), is associated with
depressive symptoms. Several hypotheses have been proposed
to characterize MDD. The monoamine hypothesis (Krishnan
and Nestler, 2008; Pittenger and Duman, 2008) suggests that a
decrease in monoamine function can lead to depression. Among
the monoamine projections from mid-brain to brainstem nuclei
are: (1) dopamine from the ventral tegmental area (VT area);
(2) serotonin from dorsal raphe in the periaqueductal gray area
(PAG); and (3) noradrenaline from locus coeruleus. Secondary
neuroplasticity on a cellular level is also induced by some
antidepressants that acutely increase synaptic monoamines.
In addition, the brain-derived neurotrophic factor (BDNF)
hypothesis (Nestler and Carlezon, 2006; Krishnan and Nestler,
2008; Pittenger and Duman, 2008) implies that an increase
in BDNF at the VT area and nucleus accumbens (NAc)
may increase neurovegetative symptoms associated with
depression.
Due to the heterogeneity ofMDD, about a third of the patients
suffering from the disorder are resistant to pharmacological
antidepressants and/or psychotherapy. Neuromodulation
therapies have emerged as potential treatments for depression.
Dorsolateral prefrontal cortex (DLPFC) and ventromedial
prefrontal cortex (VMPFC) are two of the main targets of
neuromodulation therapy. These two targets exhibit opposite
metabolic activity in the pathological depressed state (VMPFC:
hyper, DLPFC: hypo; Ressler and Mayberg, 2007; Koenigs and
Grafman, 2009; Kopell et al., 2011; Pathak et al., 2013). Deep
brain stimulation (DBS) at the subgenual ACC (sACC) of the
VMPFC network has shown promising results (Mayberg et al.,
2005; Lozano et al., 2008; Mayberg, 2009; Hamani et al., 2010,
2011; Holtzheimer et al., 2012). The mechanisms of action in
DBS are likely complex; however, a suppression of activity at
the sACC has generally been reported to be correlated with
improvement in depressive symptoms. Conversely, excitatory,
noninvasive stimulation at the DLPFC via repetitive transcranial
magnetic stimulation (rTMS) has efficaciously ameliorated
depressive symptoms for patients (O’Reardon et al., 2007;
Fitzgerald et al., 2009; Herbsman et al., 2009; Downar and
Daskalakis, 2013). Lesion studies and advances in neuroimaging
have provided evidence of the role of PFC in depression. In this
study, we applied excitatory rTMS at the DLPFC because of its
superficial location and because it plays a major role in higher
cognitive functions and affective regulation.
rTMS alters neuronal activity directly beneath the excitation
coil and at distant associated areas, as mediated by functional
connections (Walsh and Cowey, 2000; Goodwin and Butson,
2015). Slow rTMS (<1 Hz) has been shown to be inhibitory,
whereas fast rTMS (>5 Hz) is considered excitatory (Chen et al.,
1997; Nakamura et al., 1997; Burt et al., 2002; Lefaucheur,
2008). Recent studies have investigated TMS as both a priming
method and a treatment option for depression (Nahas et al.,
2001; O’Reardon et al., 2007; Herbsman et al., 2009). The
stimulation location and intensity, which are determined based
on resting motor threshold (RMT), are important parameters
in rTMS therapy. Lastly, magnetoencephalography (MEG) or
electroencephalography (EEG) have been used to investigate
local responses and remote interactions induced by rTMS
(Siebner et al., 2009; Thut and Pascual-Leone, 2010).
In terms of possible biomarkers of MDD, several studies
have investigated electrophysiological correlates as predictors
of clinical response. Pre-treatment increase in theta power
at the ACC as computed with EEG source imaging may
reflect increased metabolism in ACC and is correlated with
anti-depressive response (Pizzagalli, 2011; Spronk et al., 2011;
Olbrich and Arns, 2013). Greater alpha power and hemispheric
asymmetry have also been reported as potential predictors of
response (Ulrich et al., 1984; Bruder et al., 2008; Breitenstein
et al., 2014). In addition to resting-state studies, event-
related potentials (ERPs) have been assessed in context of
depression. Strong pre-treatment loudness dependent auditory
evoked potentials (LDAEPs; Gallinat et al., 2000; Juckel et al.,
2007) and P300 (Kalayam and Alexopoulos, 1999) have been
associated with antidepressive response after drug treatment.
These biomarkers in response to an auditory stimulus are
modulated by the serotonergic system (Breitenstein et al., 2014).
We used resting-state MEG to assess possible longitudinal
changes induced by high-frequency rTMS therapy. MEG source
imaging is a functional neuroimaging method that senses
magnetic fields generated by neural activity (Baillet et al., 2001).
Specifically, scalp MEG recordings are generated essentially
by synchronous postsynaptic currents driven by assemblies of
pyramidal neurons oscillating over a relatively wide frequency
spectrum. MEG imaging has excellent temporal resolution
(millisecond) and magnetic fields are less distorted by skull
and scalp tissues than EEG signals. This enables more robust
modeling of neural generators in terms of mapping local activity
and interregional coupling, based on time-dependent measures
(Baillet et al., 2001; Gross et al., 2013).
Choosing left-dorsolateral prefrontal cortex (L-DLPFC)
as a target for stimulation remains ambiguous due its broad
anatomical definition. In a resting-state functional magnetic
resonance imaging (fMRI) study (Fox et al., 2012a), measures
from healthy participants were used to develop a connectivity-
based targeting strategy to identify optimized L-DLPFC
coordinates for stimulation in depressed patients. The approach
included a paired comparison of the functional connectivity (FC)
between two sites that previously showed clinical significance,
and a correlation analysis between connectivity measures and
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clinical efficacy based on a model developed by Herbsman et al.
(2009). The results indicate that better clinical efficacy was
obtained when L-DLPFC coordinates were negatively correlated
with sACC, which accounted for 70% of the variance in clinical
efficacy. This is in line with the view of MDD as a ‘‘network
disease’’ because it affects multiple, anatomically distributed
brain regions.
FC is a rapidly developing subfield of neuroimaging that has
contributed to better definition and testing of network models
in clinical and cognitive neuroscience (Schoffelen and Gross,
2009; Sakkalis, 2011). In line with the theory of communication
through coherence as a vehicle of FC in the brain, we computed
magnitude-squared coherence between regions of interest (Fries,
2005). Coherence identifies significant frequency-dependent
correlations between two time variant signals. It is sensitive to
power and phase of neural oscillations and measures relationship
stability.
We emphasize that the efficacy of rTMS therapy in treating
MDD has previously been established and is not the focus of
this study. Rather, the current study aims to identify objective
indicators of antidepressive response to rTMS using functional
neuroimaging. The long-term goal is to predict which patients
will respond to anti-depressive treatment and to customize
neuromodulation therapy accordingly. We are interested in two
primary questions: (1) Which depressive circuits previously
targeted for DBS are modulated by successful rTMS therapy for
MDD? (2) Can changes in FC predict clinical response? Our
hypothesis is that modulation of the L-DLPFC will be reflected
through longitudinal changes in the power spectrum of local
neural oscillations, along with changes in FC with other regions
of the depressive circuit.
The major contribution of this study is to provide a bridge
between physiological markers of MDD (neuroimaging) and
clinical response to treatment. In the ‘‘Materials and Methods’’
Section, we describe the acquisition of high-temporal resolution
MEG before, during and after delivery of high-frequency rTMS.
Next, we present the approach of combining MEG source
imaging with neuronavigated-rTMS to quantify how changes in
depressive symptoms correlate with modulating specific circuits.
In the results section, we report the significance of engaging
specific functional connections in the fronto-limbic circuit for
effective MDD improvement demonstrated through frequency-
dependent connectivity analysis. Lastly, in the discussion section,
we highlight the advances in source-imaging analysis techniques
that have enabled the current study along with the limitations of
those methods. We also discuss the relevance of our findings in
the context of the field of neuromodulation and MDD.
MATERIALS AND METHODS
rTMS Delivery
High frequency (10 Hz) rTMS was administered to the L-DLPFC
(Brodmann areas 9 and 46) in five MDD patients (n = 5).
Patient selection and the decision to treat using rTMS was made
through standard care, independent of this study. In tandem
with rTMS treatment, we enrolled patients into a research study
approved by the Institutional Review Board (IRB) at the Medical
College of Wisconsin. During treatment, a total of 1000 biphasic
pulses were delivered in 25-s cycles (5 s on, 20 s off) over 20
trains per session using a Magstim Rapid stimulator (Magstim
Company Limited, Whitland, UK). Treatment was delivered for
five 15-min sessions per week over 4 weeks. Stimulation was
applied at 110% of RMT, which was determined by stimulating
the hand-knob of motor cortex. Periodic behavioral assessments
were performed with the Montgomery-Asberg depression rating
scale (MADRS).
Anatomical Imaging
High-resolution (3T) structural magnetic resonance imaging
(MRI) was acquired before treatment to assist with targeting
and navigation. It was used for definition of TMS targets
and registration with MEG imaging using FreeSurfer (Dale
et al., 1999; Martinos Center for Biomedical Imaging) and
Brainstorm (Tadel et al., 2011). A Visor neuronavigation system
(ANT Neuro, Enschede, Netherlands) was used for anatomical
targeting, and to record the position and orientation of the TMS
coil during each pulse (Figure 1).
Functional Imaging
MEG was recorded at 2000 Hz using a 306-channel VectorView
system (Elekta Neuromag Ltd, Helsinki, Finland). EOG and
EKG were also recorded simultaneous to MEG for post hoc
artifact removal. MEG was acquired at four time points: before
treatment, halfway through the treatment course (2 weeks), at the
end of the treatment course (4 weeks), and 2months after the end
of treatment. Empty-room recordings were also collected at each
acquisition for noise modeling in source imaging. During MEG,
the subject was supine under the MEG sensor array. A total of
24 min of data was collected in four 6-min runs. Each condition
(eyes-open and eyes-closed) was repeated once.
Source Analysis
MEG data for the eyes-closed condition were analyzed for
cortical source modeling, power spectral density (PSD), and FC
using Brainstorm, with default imaging parameters (Tadel et al.,
2011). The results were assessed to identify longitudinal changes
in PSD over standard frequency bands (delta = 2–4 Hz; theta =
5–7 Hz; alpha = 8–12 Hz; beta = 15–29 Hz; gamma = 30–59 Hz)
of ongoing oscillatory neural activity. Continuous signals were
cleaned from physiological and other artifacts with the signal-
space separation (SSS) method (Taulu et al., 2005) and further
corrected with specific signal-space projectors (SSP), a method
based on principal components analysis to eliminate artifacts
caused by eye-blinks and heartbeats; all were performed using
default settings in Brainstorm. The data was then processed with
a 60-Hz notch filter and a 2-Hz high-pass filter to remove residual
noise due to the power line and slow drifts of sensor DC offset.
The weighted minimum-norm estimate (wMNE), a subtype
of distributed source models, was used to generate the
source image maps, with default imaging parameters in
Brainstorm. Elementary dipole current sources were constrained
perpendicularly to the individual cortex; additive sensor
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FIGURE 1 | Neuronavigation for repetitive transcranial magnetic stimulation (rTMS) therapy. Screenshots from ANT software outline the pipeline used to
target and administer neuro-navigated rTMS. Subject-specific magnetic resonance imaging (MRI) was used for 3D reconstruction of the head volume.
High-frequency rTMS (10 Hz) at 110% of the resting motor threshold (RMT) was then applied at the left-dorsolateral prefrontal cortex (L-DLPFC) with real-time
targeting using the ANT neuro-navigation system. (+x towards the nose, +y towards the left ear, and +z in the superior direction with the origin at the center of the
head).
noise was modeled with a Gaussian distribution with known
covariance statistics estimated from empty-room recordings.
The Welch periodogram was used to obtain the PSD of
each individual source time series on the cortex. Signals from
the L-DLPFC were averaged over the stimulation area to
determine the power at that region (Goodwin and Butson,
2015). For this analysis, L-DLPFC was defined based on the
Desikan-Killiany atlas (Desikan et al., 2006) from FreeSurfer.
A linear regression analysis was performed in MATLAB
(Mathworks Inc., Natick, MA, USA) to determine if power
within a particular frequency band was correlated with clinical
improvement.
Functional Connectivity
Coherence measures computed on 10-s epochs were used to
determine FC between L-DLPFC and several regions of interest
(ROIs) previously investigated for DBS therapy: pregenual
anterior cingulate cortex (pACC) and sACC, NAc, and amygdala.
The Desikan-Killiany atlas (Desikan et al., 2006) from FreeSurfer
was used to define the ROIs. In addition, a cluster analysis
was conducted in MATLAB and visualized in SCIRun (Center
for Integrative Biomedical Computing, University of Utah).
For this analysis, each node on the L-DLPFC surface was
assigned a mean connectivity score based on the average of
its coherence with signals at each of the nodes in the other
ROIs (pACC, sACC or NAc). For example, if the L-DLPFC
was parcellated into N1 nodes and sACC was parcellated
into N2 nodes, a coherence matrix of N1 × N2 would be
computed to reflect the connectivity between L-DLPFC and
sACC. Coherence would then be averaged for all nodes in
the sACC to assign one connectivity score to each node
of the L-DLPFC, collapsing the dimensions of the initial
matrix to N1 × 1. Mean connectivity was represented with a
colormap to visualize the differential effects of sub-regions in the
L-DLPFC.
Statistical Analysis
We used a multiple regression model (Equation 1) to investigate
the relationship between change in behavior (MADRS) and
change in brain activity, controlling for time and subject effects
which were treated as categorical variables. We performed this
regression analysis for each frequency band in the source analysis
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(L-DLPFC) and the connectivity analysis (Amygdala, sACC,
pACC and NAc). We did not correct for multiple comparisons
given the exploratory nature of this study and its small sample
size. All tests were two-tailed and statistical significance was
assessed at the 0.05 level.
1MADRS ∼ Subject + Time+1Brain Activity (1)
RESULTS
Data from five MDD patients were analyzed in this study. Of
them, four were responders and one was a non-responder using
the clinical response criterion of a 40% reduction in MADRS
scores from baseline. Stimulation was applied to the L-DLPFC
using a predefined target coordinate on an anatomical MRI.
By midpoint, an improvement in depressive symptoms was
observed in responders (Table 1). These participants continued
to improve during treatment, and were still in remission at the
2-month follow-up (Figure 2).
Increase in High-Frequency Power at the
L-DLPFC Correlates with an Improvement
in Depressive Symptoms
The results from the PSD analysis indicated that an increase
in ongoing gamma (γ; 30–59 Hz) power (p(γ) = 0.01) and
beta (12–29 Hz; β) power (p(β) = 0.04) at the L-DLPFC
was significantly correlated with an improvement in depressive
symptoms (Table 2). A power distribution over cortical maps
(Figure 3) showed a marked increase of high-frequency power
bilaterally in the frontal regions of responders throughout the
course of treatment. These observations were corroborated by a
multiple regression analysis (Figure 4).
Opposite Effects of Functional
Connectivity in High and Low Frequency
Bands Between L-DLPFC and Remote
Regions
Changes in FC of L-DLPFC and several ROI in the depressive
circuit were assessed. An increase in mean coherence in the
delta band (2–4 Hz) correlated with a better clinical outcome
for depression in the connectivity analysis between L-DLPFC
and amygdala (p(δ) = 0.04; Table 2), as demonstrated by a
multiple regression model of MADRS with coherence (Figure 5).
A qualitative cluster analysis also demonstrated an increase in
TABLE 1 | Summary of Montgomery-Asberg depression rating scale
(MADRS) scores for all subjects over 4 weeks of repetitive transcranial
magnetic stimulation (rTMS) therapy and at 12-week follow-up
(R, Responder; NR, Non-responder).
MADRS scores over the course of rTMS for depression
Dep01 (R) Dep02 (NR) Dep04 (R) Dep05 (R) Dep06 (R)
Baseline 26 20 24 26 34
Midpoint 6 22 17 17 16
Endpoint 4 28 10 10 5
Follow-up 10 28 8 7 2
FIGURE 2 | Relationship between Montgomery-Asberg depression
rating scale (MADRS) scores and time. Drastic improvement occurred in
responders during the course of treatment, which persisted at least for
another 8 weeks, as demonstrated by the scores at follow-up.
DLPFC-amygdala coherence from baseline to endpoint in delta
band over the entire area of stimulation for the responders when
mapped onto the cortex. In contrast, a decrease in DLPFC-sACC
coherence in the gamma band was observed. Furthermore, the
nodes involved in modulating connectivity were common for
amygdala and sACC (Figure 6).
DISCUSSION
The target of rTMS stimulation was the L-DLPFC as this
region tends to show diminished function in individuals with
MDD. This area is implicated in working-memory, attention,
and long-term memory storage and consolidation and previous
studies have shown improvements following stimulation in
frontal cortices (Curtis and D’Esposito, 2003; Fregni et al.,
2005). We did not formally test working memory, but
questions relating to recall, attention and orientation were
asked daily to ensure there were no negative consequences of
stimulation. Our results support the hypothesis that longitudinal
changes from rTMS therapy are reflected in the PSD and
connectivity analyses of ongoing neural oscillations in the
resting-state. We emphasize that the cohort for this study
consisted of treatment-resistant patients who failed previously
at least two treatment strategies; this implies that a placebo
response is unlikely and cannot fully explain the improvement
in MDD symptoms. Furthermore, we show that correlation
of such improvement with the neurophysiological changes
captured by MEG is an objective way of assessing rTMS
therapy.
A local increase in beta and gamma power at the L-DLPFC
was correlated with an improvement in depressive symptoms.
A comparison of PSD in the right occipital cortex as a
Frontiers in Neural Circuits | www.frontiersin.org 5 July 2016 | Volume 10 | Article 50
Pathak et al. Neuromodulation for Depression
TABLE 2 | Summary of statistics from multiple regression models.
Delta Theta Alpha Beta Gamma
Coeff (p-val) Coeff (p-val) Coeff (p-val) Coeff (p-val) Coeff (p-val)
L-DLPFC (PSD) −3.27 ± 2.30 0.148 −5.66 ± 2.96 0.06 −8.59 ± 4.70 0.07 −7.56 ± 3.55 0.04∗ −9.84 ± 3.42 0.011∗
Amygdala (FC) −10.24 ± 4.80 0.040∗ −0.53 ± 3.53 0.86 4.78 ± 4.99 0.29 2.16 ± 2.97 0.42 −3.71 ± 5.14 0.420
NAc (FC) −3.12 ± 3.49 0.320 −3.91 ± 3.43 0.22 0.19 ± 7.84 0.98 −0.12 ± 6.73 0.98 −5.39 ± 6.68 0.370
sACC (FC) −0.70 ± 1.82 0.660 −0.77 ± 1.91 0.65 2.25 ± 5.92 0.67 4.79 ± 2.94 0.09 2.48 ± 6.25 0.650
pACC (FC) −0.78 ± 1.01 0.390 −0.76 ± 1.07 0.43 −3.03 ± 4.91 0.49 3.96 ± 6.63 0.50 0.11 ± 3.58 0.970
PSD, power spectral density; FC, functional connectivity; ∗ Indicates significance at α = 0.05.
control region did not result in a trend similar to the
one observed at the L-DLPFC. We posit that this increased
power may reflect a rise in metabolic activity of the DLPFC,
which was shown to contribute to improvement of symptoms.
High-frequency oscillations in the beta and gamma range
have previously been linked to increased attentional processes
(Benchenane et al., 2011). Onemechanism of gammamodulation
at a pharmacological level involves GABAergic interneurons.
These cells contribute to synchronization of the pyramidal
neurons in the DLPFC during tasks that require increased
cognitive effort. Furthermore, GABA-mediated inhibition was
shown to be sufficient in generating gamma oscillations
(Barr et al., 2009).
Previous evidence also points to GABAergic involvement
in antidepressant response (Bajbouj et al., 2005; Yue et al.,
2009). Animal models of depression have shown that GABA
agonists have antidepressant activity (Petty, 1995; Yue et al.,
2009). If inhibition is facilitated by fast acting GABAA
receptors, oscillation frequency will correspond to the gamma
band (Buzsaki, 2006). Additionally, increased cortical beta is
known to enhance the effect of GABA. Consequently, it is
plausible that increased cortical beta activity, which was also
observed in this study, boosted the effect of GABA leading to
inhibition that increased gamma power. Another consequence of
GABA-mediated inhibition is synchronization of large neuronal
populations, leading to increased long-range FC mediated by
interregional coherence (Fingelkurts et al., 2004). Alternatively,
post-synaptic targets are also known to up-regulate expression
patterns of GABAergic receptors or change their expression
pattern of the GABAergic receptor subtypes that could lead to
changes in behavioral outcome (Lloyd et al., 1989; Petty, 1995;
Brambilla et al., 2003). Though GABA may be involved, it is
difficult to determine exactly how it is exerting its effects in
this case.
Changes in synaptic plasticity are directly related to changes
measured in FC and the strength of a synapse can further
dictate the effect of inhibition (Buzsaki, 2006). The depressive
circuit targeted for DBS includes amygdala, pACC, sACC, and
the NAc (Ressler and Mayberg, 2007; Krishnan and Nestler,
2008; Holtzheimer and Mayberg, 2011). Recent developments in
source imaging methods enable a more accurate representation
of neural activity at deeper sources. Attal and Schwartz (2013)
demonstrated that realistic anatomical and electrophysiological
models of deep brain activity (DBA) allow for the estimation
of contributions from deep sources such as thalamus and
amygdala at MEG sensors. In the present study, the measures
extracted are based on integration over a large amount of time
samples (power spectrum density and coherence). Therefore,
these are equivalent to a form of averaging effect (enhancement
of SNR), which indicates that signal detection was substantially
improved. Additionally, source imaging was obtained using the
MRI obtained from each participant to account for individual
anatomy and noise statistics were captured using an empty-room
recording, and embedded into the source estimator. The most
effective targets for DBS are sACC and amygdala. This evidence
further lends credence to our results that indicate the significance
of modulating connectivity between these specific regions.
Activity in sACC contributes substantially to limbic-cortical
dysregulation (Mayberg, 1997; Greicius et al., 2007). Depression
severity has been shown to correlate positively with FC in sACC.
In addition, increased connectivity of the default mode network
(DMN) in depression was also driven by this region (Greicius
et al., 2007). Fox et al. (2012b) also showed that the magnitude of
relative disconnectivity (anticorrelation of fMRI signals) between
L-DLPFC and ACC was indicative of depression severity. The
distinct role of subregion FC is corroborated by differential
anatomical connectivity of the pACC and sACC, suggesting
a strong connection of pACC to frontal regions vs. sACC to
limbic regions (Johansen-Berg et al., 2008). These studies imply
that when an individual is improving, anti-correlation between
sACC and DLPFC weakens, which would in turn manifest in
a coherence decrease, supporting our results for the cluster
analysis that clearly show the nodes involved in decreased gamma
coherence between L-DLPFC and sACC (Figure 6). This further
suggests that part of the antidepressant mechanism enabled by
rTMS may be in the remote suppression of the sACC, which has
been shown to be hypermetabolic in depressed individuals.
Another finding is that an increase in coherence was
observed in the delta band for amygdala (Figures 5, 6).
Different frequency bands may enable the multiplexing of
channels of communication for different functional brain
networks (Lakatos et al., 2005). Communication through
coherence is thought to be regulated by inhibitory windows
(Benchenane et al., 2011). FC in lower frequency bands has
been associated with higher cognitive tasks. Previous research has
also demonstrated that anatomically distributed EEG coherence
increased in lower frequencies, particularly the delta band during
creative thought (Petsche, 1996; Gruzelier, 2009). Furthermore,
neuroimaging and neurophysiological studies have reported that
long-distance integration is coordinated by lower frequencies,
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FIGURE 3 | Changes in cortical power spectral density (PSD). These cortical maps display the normalized difference in PSD from baseline in (A) beta
(13–29 Hz) and (B) gamma (30–59 Hz) frequency bands. For the responders, there is a trend towards increase in high-frequency power bilaterally, which
corresponds to improvements in depressive symptoms, as determined by the change in MADRS (right column for each patient).
whereas short-distance networks are coordinated by higher
frequencies (Buzsaki, 2006; Leuchter et al., 2012). In particular
for mood disorders, an fMRI study (Anand et al., 2005) showed
an increase in low-frequency blood-oxygen-level dependent
(BOLD) fluctuation (LFBF) correlation between ACC and limbic
regions in patients after treatment for depression. Another
study (Chepenik et al., 2010) identified a negative correlation
in low-frequency resting-state fMRI activity between the ventral
PFC and amygdala in healthy subjects compared to those with
bipolar disorder. These reports corroborate our current findings
of increased connectivity between L-DLPFC and amygdala in the
delta band correlating with better clinical outcome.
According to an MEG study of resting-state FC (Hillebrand
et al., 2012), there is a positive correlation between patterns
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FIGURE 4 | Increase in high-frequency power at the L-DLPFC is
correlated with an improvement in depressive symptoms. Multiple
regression models of MADRS vs. PSD controlled for time and subject, show
that an increase in high-frequency power is indicative of lower MADRS or
better clinical outcome. Each symbol represents a different subject and the
trend line is a reflection of the model to display the relationship between
(A) MADRS and beta power, and (B) MADRS and gamma power.
of source power and FC. A modeling study (Chawla et al.,
1999, 2000) also showed increased phase locking between two
connected neuronal populations resulting in increases in both
power and FC. Though we did not note a statistical significance
in the connectivity analysis between L-DLPFC and sACC in
our multiple regression analysis, we would allude to the results
of our cluster analysis that align with these previous findings
and demonstrate decreased gamma connectivity between the two
regions.
Lastly, the modulation in coherence between frontal and
limbic regions was observed over the entire area of stimulation
for responders, when mean connectivity was mapped onto the
L-DLPFC. This finding implies that stimulation of responders
engaged functional connections that were relevant for clinical
improvement and nonresponders were effectively lacking in
engaging those essential connections. In a previous study
FIGURE 5 | Increase in low-frequency connectivity between L-DLPFC
and amygdala. Multiple regression models of MADRS vs. coherence show
that there is a significant linear relationship between connectivity and an
improvement in depressive symptoms. Each symbol represents a different
subject and the trend line is a reflection of the model to display the relationship
between MADRS and coherence in the delta band.
investigating chronic epidural cortical stimulation (EpCS)
for depression (Kopell et al., 2011; Pathak et al., 2013),
stimulation using the mixed mode polarity, in which the
configuration of the active electrode alternated between anode
and cathode in a pseudorandom manner, was effective in
achieving an antidepressant response. This response was likely
due to recruitment of a wider range of neurons owing to
characteristic differences in anodic and cathodic stimulations
(Wongsarnpigoon and Grill, 2008; Pathak et al., 2013). Another
study (Riva-Posse et al., 2014) investigating fiber tracts concluded
that the involvement of bilateral forceps minor, the cingulate
bundle, and short descending midline fibers was predictive of
clinical response. Riva-Posse et al. (2014) emphasized that the
anatomical location of active electrodes was not the source of
variability, but instead it was the hub location where these three
fibers intersected that determined potential of response.
In terms of study design, a sham group was not included
because the study was not testing actual treatment efficacy of
TMS. Instead, our goal was to conduct a longitudinal study
to evaluate neuroimaging changes in patient volunteers
showing MDD clinical improvements following TMS
treatment. While this still does not entirely rule out a
possible placebo effect, it remains highly unlikely since
these patients had failed at least two previous treatment
options that are otherwise effective. Further, the STAR ∗ D
report elegantly explains that there is a reduction in
remission rates as the number of treatment steps increase
(Rush et al., 2006).
When working with resting state signals, we cannot disregard
the possibility of negative self-talk or rumination. Future studies
should attempt to control for this. However, this is a pilot
study. Further, resting state here only implies task-free; how
an individual controls their thoughts are beyond the scope of
this study. In fact, this state of rumination might reflect the
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FIGURE 6 | rTMS modulates connectivity over the L-DLPFC in responders. L-DLPFC/amygdala coherence in delta band (bottom) increased from baseline to
endpoint over the entire area of stimulation for responders. An opposite effect was observed with a decrease in L-DLPFC/subgenual anterior cingulate cortex (sACC)
coherence in gamma band (top) from baseline to endpoint over the entire area of stimulation for responders. The nodes in L-DLPFC contributing to change in
connectivity are common for both amygdala and sACC for all patients.
resting state of an MDD patient. Additionally, our data has been
averaged over several segments of time for the analysis. If these
occurrences are spontaneous, it is likely that their effect will be
eliminated.
There are a few limitations that should be addressed in
future studies as the field advances. First, interaction of TMS
with medication is not clearly understood. There is a possibility
that changes in medication can affect cortical excitability which
might necessitate a re-evaluation of the TMS ‘‘dose’’. Secondly,
we analyzed data from a relatively small sample size. As this
is a small patient cohort, we did not correct for multiple
comparisons which could increase the probability of a Type
I error. However, the longitudinal nature of our study design
provides the opportunity to observe changes at an individual
level over the course of neuromodulation therapy. With a push
towards precision medicine, it becomes important to measure
improvement in a patient-specific manner. Additionally, our
findings regarding neuroimaging correlates of improvement in
depression take into account response and non-response, and the
results are selective for specific anatomical regions.
CONCLUSION
The primary finding from this study is that in addition to
local changes, high-frequency rTMS modulates remote nodes
of the depressive circuit during an effective clinical response.
This conclusion was reached by combining anatomical targeting
(from rTMS navigation) with source analysis and FC as
determined from MEG. We postulate that this approach could
fill two important gaps in our current knowledge. First, it
could improve identification of specific regions and functional
connections to target in order to maximize the therapeutic
response. Second, this approach could provide insights about
common mechanisms for different types of neuromodulation
therapy including rTMS, cortical stimulation and DBS.
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